Wegovy vs Mounjaro: Which Weight Management Injection Suits You?
Compare Wegovy and Mounjaro: Key Mechanisms and UK Availability
When you compare Wegovy and Mounjaro, the fundamental difference lies in their mechanisms of action, though both are designed to support weight management as prescription-only medicines. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that targets two hormone pathways simultaneously. This dual action means Mounjaro works on both GLP-1 receptors (like Wegovy) plus glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially offering a different appetite control experience. Both treatments require a clinical assessment and are available through EverydayMeds' GPhC-registered pharmacy service (#9012878), with genuine manufacturer pens delivered via temperature-controlled logistics. Your prescriber will help determine which mechanism aligns better with your medical history and weight management goals during the online consultation process.
The practical differences extend beyond mechanisms when you compare Wegovy and Mounjaro for UK purchase decisions. Wegovy follows a structured 20-week dose escalation from 0.25mg to 2.4mg maintenance, with each dose taken once weekly, whilst Mounjaro escalates from 2.5mg to up to 15mg over a different timeframe. Both require injection technique training, though Wegovy's FlexTouch pen system and Mounjaro's KwikPen offer slightly different user experiences. Storage requirements also differ significantly: Wegovy maintains potency for 6 weeks at room temperature once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for frequent travellers. At EverydayMeds, we ensure both treatments arrive with full cold-chain integrity and provide comprehensive injection training materials regardless of which your prescriber recommends.
Wegovy vs Mounjaro Pricing: Compare Costs and UK Bundle Options
Understanding the cost structure helps you compare Wegovy and Mounjaro effectively for long-term budgeting, as both require ongoing monthly investments in your weight management journey. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose, with new customers applying code FIRST40 at checkout to reach these prices. Our bundle options provide supply continuity: the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99 for your first three months, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance pens for £649.99. Mounjaro follows its own pricing structure, typically starting higher than Wegovy's initial doses but with different escalation costs. Both treatments qualify for our returning customer discount code DOSE25 on subsequent orders, making long-term treatment more accessible through our UK-registered pharmacy service.
The value comparison between Wegovy and Mounjaro extends beyond pure pen costs to include consultation quality, delivery reliability, and ongoing prescriber support throughout your weight management journey. EverydayMeds includes a comprehensive clinical assessment, prescriber review (standard 3 working days, express 24 hours), and next-day cold-chain delivery in all prices, ensuring you receive genuine manufacturer products with full traceability. Our 2-pen bundles like the Progress Duo (0.5mg & 1mg Wegovy) at £189.99 provide seamless dose transitions, whilst equivalent Mounjaro combinations follow different pricing models. Both treatments represent significant monthly investments—typically £150-250+ during maintenance phases—but the potential health benefits and clinical trial outcomes support their cost-effectiveness when prescribed appropriately. Payment plans and subscription options may be available for both medications, helping spread costs across your treatment timeline.
Clinical Evidence: Compare Wegovy and Mounjaro Trial Results
When you compare Wegovy and Mounjaro through clinical trial data, both demonstrate substantial efficacy in supporting weight management alongside reduced-calorie diets and increased physical activity, though direct head-to-head trials remain limited. Wegovy's STEP programme showed patients may achieve approximately 15% average weight loss at 68 weeks in the STEP 1 trial (vs 2.4% with placebo), whilst STEP 5 demonstrated sustained clinically studied weight loss at 2 years, according to Wilding et al., NEJM, 2021. The recent SELECT trial revealed that Wegovy may also reduce major cardiovascular events by 20% (HR 0.80), adding potential heart health benefits beyond weight management. These results position Wegovy as a clinically-proven option for long-term weight control when used under medical supervision.
Mounjaro's SURMOUNT trial programme demonstrates its dual GIP/GLP-1 mechanism may support different weight loss patterns, though comparing percentages directly between STEP and SURMOUNT trials can be misleading due to different study populations, endpoints, and methodologies. Both medications showed their greatest efficacy when combined with lifestyle interventions, reinforcing that neither works as a standalone solution but rather as part of comprehensive weight management strategies. The clinical evidence supports both treatments as effective options, with individual patient factors—medical history, tolerance, lifestyle considerations—often determining which performs better for specific individuals rather than one being universally superior to the other.
How Wegovy Works: GLP-1 Mechanism vs Mounjaro's Dual Action
To properly compare Wegovy and Mounjaro, understanding their distinct mechanisms explains why different patients may respond better to each treatment approach. Wegovy's semaglutide targets GLP-1 receptors in your brain's appetite control centres, mimicking the natural incretin hormone that signals fullness after eating and may reduce food cravings between meals. This GLP-1 action slows gastric emptying, meaning food stays in your stomach longer, promoting satiety with smaller portions and potentially reducing the psychological drive to overeat. The once-weekly injection maintains steady semaglutide levels, providing consistent appetite regulation throughout each seven-day cycle. Additionally, GLP-1 receptor activation may influence reward pathways in the brain, potentially reducing cravings for high-calorie foods, though individual responses vary significantly.
UK Ordering Process: Compare Wegovy and Mounjaro Access Routes
The process to compare Wegovy and Mounjaro begins with EverydayMeds' 3-minute online clinical assessment, where you'll provide medical history, current medications, weight management goals, and lifestyle factors that help determine which treatment might suit you better. Our prescribers review both options during their assessment, considering factors like your BMI, any weight-related health conditions, previous medication experiences, and practical considerations such as travel frequency (where Wegovy's superior room temperature stability might influence the decision). Once your prescriber determines eligibility and recommends either Wegovy or Mounjaro, we dispatch your genuine manufacturer pens via next-day cold-chain delivery with full temperature monitoring throughout transit. The prescription remains valid for repeat orders, though regular prescriber check-ins ensure your chosen treatment continues meeting your weight management needs effectively. Both medications require the same rigorous clinical oversight and qualification criteria under MHRA guidelines.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Life
Storage requirements present a clear practical difference when you compare Wegovy and Mounjaro for real-world use, particularly if you travel frequently or have limited refrigerator access. Wegovy pens maintain full potency for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy significantly more convenient for business travel, holidays, or irregular schedules. Both use pre-filled pen injectors—Wegovy's FlexTouch system and Mounjaro's KwikPen—but the injection experience differs slightly in pen grip, needle attachment, and dose confirmation feedback. The weekly injection schedule remains consistent for both, though Wegovy's dose escalation follows a structured 20-week timeline whilst Mounjaro uses different dose steps and timing. Both require identical injection site rotation (thigh, abdomen, upper arm) and similar injection technique training, which EverydayMeds provides through comprehensive patient information materials with every order.
Side Effect Profiles: Compare Wegovy and Mounjaro Tolerance
Both Wegovy and Mounjaro may cause similar gastrointestinal side effects during initial treatment phases, including nausea, vomiting, diarrhoea, and constipation, though individual tolerance varies significantly between patients. Wegovy's semaglutide-based mechanism typically shows peak side effects during dose escalation periods, with symptoms often improving as your body adjusts to each new strength over the 20-week titration schedule. Mounjaro's dual GIP/GLP-1 action may produce different side effect timing and intensity, though both medications share warnings about potential pancreatitis, gallbladder problems, and kidney function changes that require medical monitoring. Your prescriber will assess your risk factors for serious adverse effects when determining which treatment to recommend during the clinical assessment process.
The side effect management strategies differ slightly when you compare Wegovy and Mounjaro approaches to minimising gastrointestinal symptoms during treatment initiation. Both benefit from slower eating, smaller meal portions, avoiding high-fat foods during adjustment periods, and maintaining adequate hydration, though some patients report different tolerability patterns between semaglutide and tirzepatide mechanisms. EverydayMeds provides detailed side effect guidance with both medications, including when to contact healthcare providers, how to manage common symptoms, and red-flag warnings that require immediate medical attention. Neither medication should be stopped abruptly without prescriber consultation, and both require ongoing medical supervision throughout treatment to monitor effectiveness and detect any concerning adverse reactions early.
Making Your Decision: Buy Wegovy or Mounjaro Online UK
Your final decision to compare Wegovy and Mounjaro should prioritise clinical suitability over cost considerations, as both represent significant monthly investments that require long-term commitment for optimal results. EverydayMeds' clinical team considers your complete medical picture—BMI, comorbidities, medication history, lifestyle factors, and personal preferences—to guide recommendations during the online assessment process. Start your clinical assessment today using discount code FIRST40 for new customers or DOSE25 for returning patients, ensuring you receive genuine manufacturer products through our GPhC-registered service (#9012878). Both Wegovy and Mounjaro are available with next-day delivery once prescribed, cold-chain integrity assured, and ongoing prescriber support throughout your weight management journey. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and discover which treatment aligns best with your individual weight management goals under proper medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
